Because therapeutic strategies based on miRNA delivery are still challenging and HMGA2 is generally not or barely expressed in adult tissues while re-expressed in thyroid cancer, HMGA2 inhibition has therapeutic potential in thyroid cancer. This evidence concerns the gene HMGA2 and thyroid gland carcinoma.